Hereditary and somatic mutations of cancer associated genes, such as TP53, BRAF, ATM, and BRCA 1 and 2, are commonly found in more than one type of cancers and are associated with poor clinical outcomes and chemotherapy resistance4. This evidence concerns the gene TP53 and cancer.